![Vaccines | Free Full-Text | Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea Vaccines | Free Full-Text | Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea](https://pub.mdpi-res.com/vaccines/vaccines-11-00984/article_deploy/html/images/vaccines-11-00984-g003b.png?1684153688)
Vaccines | Free Full-Text | Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea
![Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, <i xmlns="">Haemophilus influenzae</i> type b conjugate, and hepatitis B vaccine in infants Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, <i xmlns="">Haemophilus influenzae</i> type b conjugate, and hepatitis B vaccine in infants](https://www.e-cep.org/upload//thumbnails/t1-cep-2021-00507.png)
Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, <i xmlns="">Haemophilus influenzae</i> type b conjugate, and hepatitis B vaccine in infants
![Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants](https://www.e-cep.org/upload//thumbnails/cep-2021-00507f1.jpg)
Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants
![PDF] Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in PDF] Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in](https://d3i71xaburhd42.cloudfront.net/d3e50eb3c55e0b7aaef6c0fe1efdb53c3a90ac30/4-TableIII-1.png)
PDF] Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in
Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-P
![Economic impact of switching from partially combined vaccine “Pentaxim® and hepatitis B” to fully combined vaccine “Hexaxim®” in the Malaysian National Immunization Program | BMC Health Services Research | Full Text Economic impact of switching from partially combined vaccine “Pentaxim® and hepatitis B” to fully combined vaccine “Hexaxim®” in the Malaysian National Immunization Program | BMC Health Services Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12913-021-07428-7/MediaObjects/12913_2021_7428_Fig1_HTML.png)
Economic impact of switching from partially combined vaccine “Pentaxim® and hepatitis B” to fully combined vaccine “Hexaxim®” in the Malaysian National Immunization Program | BMC Health Services Research | Full Text
![PDF) Immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type B conjugate combination vaccine (Pentaxim) with hepatitis B vaccine | Valsan Verghese - Academia.edu PDF) Immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type B conjugate combination vaccine (Pentaxim) with hepatitis B vaccine | Valsan Verghese - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/39157577/mini_magick20190223-3713-nud5j8.png?1550938193)
PDF) Immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type B conjugate combination vaccine (Pentaxim) with hepatitis B vaccine | Valsan Verghese - Academia.edu
![Sanofi Pasteur is the global market leader in all categories of aP-based pediatric combination vaccines Sanofi Pasteur is the global market leader in all categories of aP-based pediatric combination vaccines](https://ai.reportlinker.com/hubfs/sanofi-share-pentavalent-vaccine-countries.webp)
Sanofi Pasteur is the global market leader in all categories of aP-based pediatric combination vaccines
![PDF) One-year post-primary antibody persistence and booster immune response to a DTaP-IPV//PRP~T vaccine (Pentaxim) given at 18 - 19 months of age in South African children primed at 6, 10 and 14 PDF) One-year post-primary antibody persistence and booster immune response to a DTaP-IPV//PRP~T vaccine (Pentaxim) given at 18 - 19 months of age in South African children primed at 6, 10 and 14](https://0.academia-photos.com/attachment_thumbnails/46123924/mini_magick20190210-28218-1uff7pg.png?1549828002)